Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Operating Leases: 2019-2025

Historic Operating Leases for Gyre Therapeutics (GYRE) over the last 5 years, with Sep 2025 value amounting to $539,000.

  • Gyre Therapeutics' Operating Leases fell 51.04% to $539,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $539,000, marking a year-over-year decrease of 51.04%. This contributed to the annual value of $885,000 for FY2024, which is 344.72% up from last year.
  • As of Q3 2025, Gyre Therapeutics' Operating Leases stood at $539,000, which was down 30.09% from $771,000 recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Operating Leases registered a high of $1.3 million during Q2 2024, and its lowest value of $121,000 during Q4 2022.
  • Over the past 3 years, Gyre Therapeutics' median Operating Leases value was $775,500 (recorded in 2025), while the average stood at $718,375.
  • Per our database at Business Quant, Gyre Therapeutics' Operating Leases tumbled by 70.34% in 2022 and then spiked by 345.71% in 2025.
  • Over the past 5 years, Gyre Therapeutics' Operating Leases (Quarterly) stood at $408,000 in 2021, then plummeted by 70.34% to $121,000 in 2022, then spiked by 64.46% to $199,000 in 2023, then soared by 344.72% to $885,000 in 2024, then slumped by 51.04% to $539,000 in 2025.
  • Its Operating Leases stands at $539,000 for Q3 2025, versus $771,000 for Q2 2025 and $780,000 for Q1 2025.